Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 64-70

  Cui, Jing Chun ^a,b   Zhang, Bao Jun ^c   Lin, Yan Chun ^c   Wang, Quan Kai ^c   Qian, Ai Dong ^c   Nakane, Akio ^d   Hu, Dong Liang ^d   Tong, Guang Zhi ^a,e  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b DALIAN NATIONALITIES UNIVERSITY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d HIROSAKI UNIVERSITY   (Japan)

^e INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Bovine mastitis; Staphylococcus aureus; Superantigenic toxin; Vaccination

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON; GLUTATHIONE S TRANSFERASE MUTANT STAPHYLOCOCCAL ENTEROTOXIN C FUSION PROTEIN; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN FUNCTION; ANTIGENICITY; ARTICLE; BIOLOGICAL ACTIVITY; BOVINE MASTITIS; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREACTIVITY; IN VITRO STUDY; INFECTION PREVENTION; MILK; MOUSE; NONHUMAN; SOMATIC CELL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VACCINATION; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; CATTLE; CYTOKINES; ENTEROTOXINS; FEMALE; GLUTATHIONE TRANSFERASE; MASTITIS, BOVINE; MILK; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VACCINES, SYNTHETIC;

ANIMALIA; BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 77951208490     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.11.001     Document Type: Article

References (41)

1. Bavari S., Dyas B., Ulrich R.G. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J. Infect. Dis. 1996, 174:338-345.
2. Brouillette E., Malouin F. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect. 2005, 7:560-568.
3. Chang B.S., Moon J.S., Kang H.M., Kim Y.I., Lee H.K., Kim J.D., Lee B.S., Koo H.C., Park Y.H. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle. Vaccine 2008, 26:2081-2091.
4. Dinges M.M., Orwin P.M., Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13:16-34.
5. Edwards V.M., Deringer J.R., Callantine S.D., Deobald C.F., Berger P.H., Kapur V., Stauffacher C.V., Bohach G.A. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect. Immun. 1997, 65:2346-2352.
6. Fields B.A., Malchiodi E.L., Li H., Ysern X., Stauffacher C.V., Schlievert P.M., Karjalainen K., Mariuzza R.A. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 1996, 384:188-192.
7. Fitzgerald J.R., Monday S.R., Foster T.J., Bohach G.A., Hartigan P.J., Meaney W.J., Smyth C.J. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J. Bacteriol. 2001, 183:63-70.
8. Gampfer J., Thon V., Gulle H., Wolf H.M., Eibl M.M. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. Vaccine 2002, 20:1354-1364.
9. Hata E., Katsuda K., Kobayashi H., Ogawa T., Endo T., Eguchi M. Characteristics and epidemiologic genotyping of Staphylococcus aureus isolates from bovine mastitic milk in Hokkaido, Japan. J. Vet. Med. Sci. 2006, 68:165-170.
10. Holtfreter S., Broker B.M. Staphylococcal superantigens: do they play a role in sepsis?. Arch. Immunol. Ther. Exp. 2005, 53:13-27.
11. Hu D.L., Cui J.C., Omoe K., Sashinami H., Yokomizo Y., Shinagawa K., Nakane A. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection. Infect. Immun. 2005, 73:174-180.
12. Hu D.L., Omoe K., Inoue F., Kasai T., Yasujima M., Shinagawa K., Nakane A. Comparative prevalence of superantigenic toxin genes in meticillin-resistant and meticillin-susceptible Staphylococcus aureus isolates. J. Med. Microbiol. 2008, 57:1106-1112.
13. Hu D.L., Omoe K., Sasaki S., Sashinami H., Sakuraba H., Yokomizo Y., Shinagawa K., Nakane A. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J. Infect. Dis. 2003, 188:743-752.
14. Kenny K., Reiser R.F., Bastida-Corcuera F.D., Norcross N.L. Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus. J. Clin. Microbiol. 1993, 31:706-707.
15. Kum W.W., Chow A.W. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. J. Infect. Dis. 2001, 183:1739-1748.
16. LeClaire R.D., Hunt R.E., Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect. Immun. 2002, 70:2278-2281.
17. Leder L., Llera A., Lavoie P.M., Lebedeva M.I., Li H., Sekaly R.P., Bohach G.A., Gahr P.J., Schlievert P.M., Karjalainen K., Mariuzza R.A. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J. Exp. Med. 1998, 187:823-833.
18. Lee J.C. The prospects for developing a vaccine against Staphylococcus aureus. Trends Microbiol. 1996, 4:162-166.
19. Llewelyn M., Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2002, 2:156-162.
20. Lowell G.H., Kaminski R.W., Grate S., Hunt R.E., Charney C., Zimmer S., Colleton C. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect. Immun. 1996, 64:1706-1713.
21. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
22. McCormick J.K., Hirt H., Dunny G.M., Schlievert P.M. Pathogenic mechanisms of enterococcal endocarditis. Curr. Infect. Dis. Rep. 2000, 2:315-321.
23. Michie C.A. Staphylococcal vaccines. Trends Immunol. 2002, 23:461-463.
24. Miles H., Lesser W., Sears P. The economic implications of bioengineered mastitis control. J. Dairy Sci. 1992, 75:596-605.
25. Nakane A., Okamoto M., Asano M., Kohanawa M., Minagawa T. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 1995, 63:1165-1172.
26. Nakane A., Nishikawa S., Sasaki S., Miura T., Asano M., Kohanawa M., Ishiwata K., Minagawa T. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in gamma interferon-depleted mice. Infect. Immun. 1996, 64:1252-1258.
27. Narita K., Hu D.L., Tsuji T., Nakane A. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection. FEMS Immunol. Med. Microbiol. 2008, 52:389-396.
28. Neill R.J., Jett M., Crane R., Wootres J., Welch C., Hoover D., Gemski P. Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect. Immun. 1996, 64:3007-3015.
29. Nilsson I.M., Patti J.M., Bremell T., Hook M., Tarkowski A. Vaccination with a recombinant fragment of collagen adhesion provides protection against Staphylococcus aureus-mediated septic death. J. Clin. Invest. 1998, 101:2640-2649.
30. Omoe K., Hu D.L., Takahashi-Omoe H., Nakane A., Shinagawa K. Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates. FEMS Microbiol. Lett. 2005, 246:191-198.
31. Schlievert P.M. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J. Allergy Clin. Immunol. 2001, 108:S107-110.
32. Schlievert P.M., Jablonski L.M., Roggiani M., Sadler I., Callantine S., Mitchell D.T., Ohlendorf D.H., Bohach G.A. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect. Immun. 2000, 68:3630-3634.
33. Stiles B.G., Krakauer T., Bonventre P.F. Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect. Immun. 1995, 63:1229-1234.
34. Sutra L., Poutrel B. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus. J. Med. Microbiol. 1994, 40:79-89.
35. Ulrich R.G., Olson M.A., Bavari S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 1998, 16:1857-1864.
36. Vintov J., Aarestrup F.M., Zinn C.E., Olsen J.E. Association between phage types and antimicrobial resistance among bovine Staphylococcus aureus from 10 countries. Vet. Microbiol. 2003, 95:133-147.
37. Wilson D.J., Gonzalez R.N., Das H.H. Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J. Dairy Sci. 1997, 80:2592-2598.
38. Woody M.A., Krakauer T., Stiles B.G. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model. Vaccine 1997, 15:133-139.
39. Woody M.A., Krakauer T., Ulrich R.G., Stiles B.G. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. J. Infect. Dis. 1998, 177:1013-1022.
40. Zhang B.-J., Cui J.-C., Zhang X., Lin Y.-C., Qian A.-D., Tong G.-Z., Hu D.-L., Nakane A., Wang Q.-K. Immunization with glutathione S-transferase-fused mutant staphylococcal enterotoxin C protects against Staphylococcus aureus-induced mastitis in mouse model. Chin. J. Prev. Vet. Med. 2009, 31:557-562.
41. Zecconi A., Piccinini R., Fox L.K. Epidemiologic study of intramammary infections with Staphylococcus aureus during a control program in nine commercial dairy herds. J. Am. Vet. Med. Assoc. 2003, 223:684-688.